Client News
InflaRx to Present at the H.C. Wainwright Global Investment Conference
Marinomed to attend several upcoming investor conferences
InflaRx Reports First Quarter 2022 Financial and Operating Results and Provides Strategic Update
HepaRegeniX reports positive topline results of its Phase 1 Clinical Trial of HRX-0215, a First-In-Class MKK4 inhibitor
World leading C. difficile scientists to present landmark data on the ability of NTCD-M3 to colonise the gut after antibiotic administration
avateramedical robot-assisted surgery system progresses to clinical use
Andera Partners supports Tubulis in a €60 million Series B financing to accelerate the development of its ADCs
Destiny Pharma strengthens Executive Management Team with the appointment of Dr Yuri Martina as Chief Medical Officer
Abivax publishes Universal Registration Document 2022 “Document d’Enregistrement Universel”